The Hordaland Health Study
NCT03013725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36000
Last updated 2017-01-06
Summary
The Hordaland Health Studies (HHS) were conducted in 1992-93 (The Homocysteine study) and in 1997-99 (HUSK). Both surveys were conducted as a joint project between the University of Bergen, the Norwegian Health Screening Service (SHUS) (now part of the National Institute of Public Health) and the Municipal Health Service in Hordaland.
The main focus of the studies is on chronic diseases including cardiovascular disease, cancer, osteoporosis, anxiety and depression. Some projects focus on psychosocial factors, occupational research, musculoskeletal diseases, urinary incontinence and mapping of drug use. The main purpose of the surveys is to gather information so that disease ultimately can be prevented.
Approximately 36,000 residents of Hordaland county participated in the studies, ca. 18,000 in 1992-93 and ca. 26,000 in 1997-99. About 7,000 of those who participated in the 1992-93 survey also participated in 1997-99.
Conditions
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Part of CONOR, and participates in the Norwegian Epidemiologic Osteoporosis Studies
collaborator UNKNOWN -
University of Bergen
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-01-31
- Primary Completion
- 1999-06-30
- Completion
- 1999-06-30
More Related Trials
-
Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs
NCT05322967 ·Status: RECRUITING ·Phase: NA
-
Home Reported Outcomes in PNH
NCT06411626 ·Status: RECRUITING
-
Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function
NCT01822860 ·Status: WITHDRAWN ·Phase: PHASE4
-
DASH Diet Intervention for Systemic Hypertension in Adolescents
NCT06616818 ·Status: WITHDRAWN ·Phase: NA
-
Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight Reduction
NCT01310088 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension
NCT01679652 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852 ·Status: COMPLETED ·Phase: PHASE4
-
Hormonal Influences on Diuresis
NCT04891926 ·Status: COMPLETED ·Phase: NA
-
Resistant Arterial Hypertension Cohort Study
NCT01083017 ·Status: COMPLETED
-
Treatment of Mild Hypertension Study (TOMHS)
NCT00000522 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
NCT06495983 ·Status: RECRUITING
-
Metabolomics of the Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern
NCT03403166 ·Status: COMPLETED
-
Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
NCT01380717 ·Status: COMPLETED ·Phase: PHASE4
-
The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients
NCT05165823 ·Status: COMPLETED ·Phase: NA
-
High Blood Pressure in the Young
NCT00005138 ·Status: COMPLETED
-
The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
NCT02527837 ·Status: UNKNOWN ·Phase: PHASE1
-
Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency
NCT06756620 ·Status: COMPLETED
-
Blood Pressure Control in Juveniles - Longitudinal Study
NCT00005181 ·Status: COMPLETED
-
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
NCT06208072 ·Status: RECRUITING ·Phase: NA
-
Predictive Properties of the Hyperventilation Provocation Test for the Diagnosis of the Hyperventilation Syndrome
NCT05100290 ·Status: COMPLETED
-
Hypertension Detection and Follow-up Program (HDFP)
NCT00000485 ·Status: COMPLETED ·Phase: PHASE3
-
Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.
NCT01951196 ·Status: UNKNOWN
-
Changes in Renal Function and Body Composition in Pulmonary Hypertension
NCT03039972 ·Status: COMPLETED
-
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
NCT04193046 ·Status: COMPLETED ·Phase: EARLY_PHASE1